F18.121 Inhalant abuse with intoxication delirium

Name of the Condition

• Common Name: Inhalant Abuse with Intoxication Delirium
• Medical Term: Inhalant Abuse with Intoxication Delirium

Summary

Inhalant abuse with intoxication delirium is a condition characterized by the intentional misuse of inhalants—substances that produce chemical vapors—to achieve psychoactive effects, accompanied by acute intoxication and delirium. Delirium involves a disturbance in attention and awareness, often with cognitive changes or perceptual disturbances, that develops during or shortly after inhalant use. This condition can impair cognitive and physical functioning and may lead to dependence, organ damage, or other substance-related health issues, affecting an individual's health and daily functioning.

Causes

Inhalant abuse with intoxication delirium is driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to acute intoxication, dependence, and related health issues, including delirium.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Disturbance in attention and awareness.
• Perceptual disturbances (e.g., hallucinations).
• Disorganized thinking or speech.
• Altered level of consciousness.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other causes of delirium, such as metabolic or infectious conditions. The diagnosis is based on the presence of inhalant use, acute intoxication, and delirium symptoms that cannot be better explained by another medical condition or substance use.

Treatment Options

Treatment focuses on managing delirium, addressing inhalant abuse, and providing supportive care. This may include:

• Stabilizing the patient in a safe environment.
• Monitoring and managing withdrawal symptoms if present.
• Addressing underlying medical or psychiatric conditions.
• Referral to substance use disorder treatment programs.
• Pharmacological interventions to manage symptoms (e.g., antipsychotics for agitation).

Prognosis and Follow-Up

The prognosis depends on the severity of delirium, the extent of inhalant abuse, and the presence of comorbid conditions. Early intervention and adherence to treatment improve outcomes. Follow-up care is essential to monitor for relapse, manage chronic effects of inhalant use, and address any ongoing mental health needs.

Complications

• Persistent cognitive impairment.
• Organ damage (e.g., liver, kidney, or neurological).
• Increased risk of accidents or injuries due to impaired judgment.
• Worsening of mental health conditions.
• Dependence or addiction.

Lifestyle & Prevention

• Avoiding inhalant use and educating others about its risks.
• Ensuring proper storage and supervision of household or industrial products that may be misused.
• Seeking help for substance use disorders early.
• Engaging in healthy coping mechanisms and stress management.

When to Seek Professional Help

Seek immediate medical attention if experiencing symptoms of delirium, such as confusion, hallucinations, or altered consciousness, especially after inhalant use. Contact a healthcare provider for ongoing substance use concerns or if experiencing withdrawal symptoms.

Tips for Medical Coders

When coding for inhalant abuse with intoxication delirium, ensure documentation supports the presence of both acute intoxication and delirium. Verify that the delirium is directly related to inhalant use and not attributable to another medical condition. Accurate coding requires clear documentation of the substance involved, the timing of symptoms, and the clinical assessment of delirium.